Literature DB >> 24065187

Initial experiences with endoscopic rhino-neurosurgery in Amsterdam.

Rick de Bruin1, Wouter R van Furth, Dagmar Verbaan, Christos Georgalas, W F Fokkens, S M Reinartz.   

Abstract

Endoscopic surgery of the skull base has been on the rise for several years. Endoscopic access for surgery can be achieved from the frontal sinus anteriorly along the skull base to the odontoid process posterior inferiorly. An endoscope is inserted through one nasal corridor and allows visualization of the working field and up to three surgical instruments can be used to address the lesion. This is called the "two nostrils-four hands technique". This is a retrospective study of 67 cases. Setting of the study is an Amsterdam University hospital. Cases were identified in the department of otorhinolaryngology and department of neurosurgery database. All patients operated between 1 January, 2008 and 1 February, 2012 with pituitary tumours that extend beyond the sella, sinonasal tumours and all non-pituitary skull-base tumours were included. Mean tumour diameter was 3.8 cm. We performed a near-to-gross total resection in 92% of cases where we intended to perform a total resection. The most frequent complication was CSF leakage. This study demonstrates that this technique is safe and reliable. What is needed is a dedicated team, which includes a dedicated anesthesiologist, endocrinologist, ophthalmologist, and radiation oncologist.

Entities:  

Mesh:

Year:  2013        PMID: 24065187     DOI: 10.1007/s00405-013-2662-2

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  44 in total

1.  Endoscopic transsphenoidal approach: adaptability of the procedure to different sellar lesions.

Authors:  Enrico de Divitiis; Paolo Cappabianca; Luigi Maria Cavallo
Journal:  Neurosurgery       Date:  2002-09       Impact factor: 4.654

Review 2.  Endoscopy and transsphenoidal surgery.

Authors:  Paolo Cappabianca; Enrico de Divitiis
Journal:  Neurosurgery       Date:  2004-05       Impact factor: 4.654

Review 3.  Extended endoscopic endonasal skull base surgery: from the sella to the anterior and posterior cranial fossa.

Authors:  Amanda Oostra; Wouter van Furth; Christos Georgalas
Journal:  ANZ J Surg       Date:  2012-01-17       Impact factor: 1.872

4.  Use of Hemostatic Matrix for Hemostasis of the Cavernous Sinus during Endoscopic Endonasal Pituitary and Suprasellar Tumor Surgery.

Authors:  Anupama D Bedi; Steven A Toms; Amir R Dehdashti
Journal:  Skull Base       Date:  2011-05

Review 5.  Expanded endonasal approach: the rostrocaudal axis. Part I. Crista galli to the sella turcica.

Authors:  Amin Kassam; Carl H Snyderman; Arlan Mintz; Paul Gardner; Ricardo L Carrau
Journal:  Neurosurg Focus       Date:  2005-07-15       Impact factor: 4.047

6.  Transsphenoidal operation on craniopharyngiomas with extrasellar extensions. The advantage of the operating endoscope [proceedings].

Authors:  E Halves; K A Bushe
Journal:  Acta Neurochir Suppl (Wien)       Date:  1979

7.  A novel reconstructive technique after endoscopic expanded endonasal approaches: vascular pedicle nasoseptal flap.

Authors:  Gustavo Hadad; Luis Bassagasteguy; Ricardo L Carrau; Juan C Mataza; Amin Kassam; Carl H Snyderman; Arlan Mintz
Journal:  Laryngoscope       Date:  2006-10       Impact factor: 3.325

8.  Value of endoscopy for maximizing tumor removal in endonasal transsphenoidal pituitary adenoma surgery.

Authors:  Nancy McLaughlin; Amy A Eisenberg; Pejman Cohan; Charlene B Chaloner; Daniel F Kelly
Journal:  J Neurosurg       Date:  2012-12-14       Impact factor: 5.115

9.  Outcomes following endoscopic, expanded endonasal resection of suprasellar craniopharyngiomas: a case series.

Authors:  Paul A Gardner; Amin B Kassam; Carl H Snyderman; Ricardo L Carrau; Arlan H Mintz; Steven Grahovac; Susan Stefko
Journal:  J Neurosurg       Date:  2008-07       Impact factor: 5.115

10.  Transsphenoidal surgery of parasellar pituitary adenomas.

Authors:  R Fahlbusch; M Buchfelder
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.